Beverly Hills Private Wealth, LLC Myriad Genetics Inc Transaction History
Beverly Hills Private Wealth, LLC
- $495 Billion
- Q4 2024
A detailed history of Beverly Hills Private Wealth, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Beverly Hills Private Wealth, LLC holds 11,229 shares of MYGN stock, worth $116,107. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,229
Previous 12,856
12.66%
Holding current value
$116,107
Previous $352 Million
56.28%
% of portfolio
0.03%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding MYGN
# of Institutions
228Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$157 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$110 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$62.1 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$57.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$44.9 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $834M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...